pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

ADLYXIN (LIXISENATIDE) — FDA approval

November 1, 2024ADLYXINupdated 5mo ago
community read0 votes

Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 6

  • approvalADLYXIN (LIXISENATIDE) — FDA approvalMar 12, 2026 · 200d ago
  • approvalADLYXIN (LIXISENATIDE) — FDA approvalMay 28, 2025 · 488d ago
  • approvalADLYXIN (LIXISENATIDE) — FDA approvalSep 28, 2023 · 1096d ago
  • approvalADLYXIN (LIXISENATIDE) — FDA approvalJun 10, 2022 · 1571d ago
  • approvalADLYXIN (LIXISENATIDE) — FDA approvalJul 30, 2021 · 1886d ago
  • approvalADLYXIN (LIXISENATIDE) — FDA approvalJul 27, 2016 · 3715d ago

same company · ±60 days · 4

  • approvalToujeo LA: SOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalNov 1, 2024
  • approvalRIFATER: RIFATER (ISONIAZID) — FDA approvalOct 10, 2024
  • approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalOct 10, 2024
  • approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalOct 10, 2024

🐶 often sniffed alongside

top 4
  • tagApproval28 co-mentions · 7 sources
  • company$SNYSanofi14 co-mentions · 7 sources
  • company$SNYNFSanofi14 co-mentions · 7 sources
  • companySanofi-Aventis US LLC14 co-mentions · 7 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?